Kunwar Shailubhai
Corporate Officer/Principal chez Baruch S. Blumberg Institute
Postes actifs de Kunwar Shailubhai
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Baruch S. Blumberg Institute | Corporate Officer/Principal | - | - |
Historique de carrière de Kunwar Shailubhai
Anciens postes connus de Kunwar Shailubhai
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TIZIANA LIFE SCIENCES LTD | Chief Executive Officer | - | 01/08/2022 |
| Chief Tech/Sci/R&D Officer | - | 01/08/2022 | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Director/Board Member | 01/01/2008 | 01/08/2022 |
| Chief Executive Officer | 01/01/2008 | - | |
| Chief Tech/Sci/R&D Officer | 01/01/2008 | 15/07/2022 | |
| ACCUSTEM SCIENCES, INC. | Director/Board Member | - | 20/06/2022 |
| OKYO PHARMA LIMITED | Director/Board Member | 06/07/2017 | 17/06/2021 |
| ACTAVIA LIFE SCIENCES, INC. | Director/Board Member | 01/08/2016 | 23/12/2020 |
| Chief Executive Officer | 21/04/2017 | 06/02/2020 | |
| Independent Dir/Board Member | 01/08/2016 | 21/04/2017 | |
| SYNERGY PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01/07/2008 | 01/05/2017 |
| Founder | 01/01/2001 | 01/05/2017 | |
| Corporate Officer/Principal | 01/01/2001 | 01/07/2008 | |
| Pawfect Foods, Inc. | Chief Tech/Sci/R&D Officer | - | 11/08/2008 |
Drug Discovery Facility
 Drug Discovery Facility Pharmaceuticals: MajorHealth Technology Part of SCYNEXIS, Inc., Drug Discovery Facility provides research into drug-discovery processes. The private company is based in Cambridge, UK. Drug Discovery Facility was acquired by SCYNEXIS, Inc. from Aventis Cropscience on October 02, 2001. | Corporate Officer/Principal | 01/01/2003 | 01/01/2008 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Kunwar Shailubhai
| University of Missouri | Masters Business Admin |
| University of Baroda | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
| Royaume-Uni | 4 |
| Canada | 2 |
Opérationnelle
| Corporate Officer/Principal | 5 |
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
Sectorielle
| Health Technology | 9 |
| Consumer Services | 4 |
| Retail Trade | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| OKYO PHARMA LIMITED | Health Technology |
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| ACCUSTEM SCIENCES, INC. | Health Technology |
| TIZIANA LIFE SCIENCES LTD | Health Technology |
| Entreprise privées | 7 |
|---|---|
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
| Pawfect Foods, Inc. | Retail Trade |
Active With Me, Inc.
 Active With Me, Inc. Miscellaneous Commercial ServicesCommercial Services Active With Me, Inc. provides online resources that seamlessly offer travelers unique, highly relevant and user-friendly information on activity-based travel. Its listings will be provided for product and service providers of interest to the activity-based traveler. The company was founded on December 6, 2012 and is headquartered in Sarnia, Canada. | Commercial Services |
Drug Discovery Facility
Drug Discovery Facility Pharmaceuticals: MajorHealth Technology Part of SCYNEXIS, Inc., Drug Discovery Facility provides research into drug-discovery processes. The private company is based in Cambridge, UK. Drug Discovery Facility was acquired by SCYNEXIS, Inc. from Aventis Cropscience on October 02, 2001. | Health Technology |
| Baruch S. Blumberg Institute | |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Kunwar Shailubhai
- Expérience
